Research graph
References from Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics
2021 · External reference
The impact of obesity on breast cancer diagnosis and treatment
10.1007/s11912-019-0787-1 · 2019 · External reference
The leptin axis and its association with the adaptive immune system in breast cancer
10.3389/fimmu.2021.784823 · 2021 · External reference
10.1038/s41568-021-00388-4
10.1038/s41568-021-00388-4 · External reference
Autophagy mediates leptin-induced migration and ERK activation in breast cancer cells
10.3389/fcell.2021.644851 · 2021 · External reference
Leptin promotes the proliferation and migration of human breast cancer through the extracellular-signal regulated kinase pathway
10.3892/mmr.2013.1786 · 2014 · External reference
10.3892/etm.2017.4291
10.3892/etm.2017.4291 · External reference
10.1016/j.coph.2016.10.003
10.1016/j.coph.2016.10.003 · External reference
Obesity and breast cancer: role of leptin
10.3389/fonc.2019.00596 · 2019 · External reference
10.1177/1178223419898458
10.1177/1178223419898458 · External reference
The multifactorial role of leptin in driving the breast cancer microenvironment
10.1038/nrendo.2011.184 · 2011 · External reference
Molecular modulators of celastrol as the keystones for its diverse pharmacological activities
10.1016/j.biopha.2018.11.051 · 2019 · External reference
Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells
10.1016/j.ejphar.2018.10.043 · 2019 · External reference
Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway
10.1158/0008-5472.can-09-3201 · 2010 · External reference
Anticancer effect of celastrol on human triple negative breast cancer: possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways
10.1016/j.yexmp.2015.03.031 · 2015 · External reference
10.1038/s41591-019-0358-x
10.1038/s41591-019-0358-x · External reference
Celastrol in metabolic diseases: Progress and application prospects
10.1016/j.phrs.2021.105572 · 2021 · External reference
10.1038/325809a0
10.1038/325809a0 · External reference
10.1177/0963689720926157
10.1177/0963689720926157 · External reference
10.4161/cc.26984
10.4161/cc.26984 · External reference
MyD88 mediates colorectal cancer cell proliferation, migration and invasion via NF-κB/AP-1 signaling pathway
2020 · External reference
10.1038/s41467-019-11193-x
10.1038/s41467-019-11193-x · External reference
In vitro effects of resistin on epithelial to mesenchymal transition (EMT) in MCF-7 and MDA-MB-231 breast cancer cells - qRT-PCR and Westen blot analyses data
10.1016/j.dib.2019.104118 · 2019 · External reference
The multifaceted mechanism of leptin signaling within tumor microenvironment in driving breast cancer growth and progression
2014 · External reference
10.1016/j.clbc.2012.12.002
10.1016/j.clbc.2012.12.002 · External reference
10.1007/s11033-018-4474-3
10.1007/s11033-018-4474-3 · External reference
10.1016/j.cell.2015.05.011
10.1016/j.cell.2015.05.011 · External reference
10.4093/dmj.2019.0124
10.4093/dmj.2019.0124 · External reference
10.3892/or.2021.8040
10.3892/or.2021.8040 · External reference
10.3390/biomedicines9050482
10.3390/biomedicines9050482 · External reference
10.1016/j.csbj.2019.04.012 · Admitted local publication
10.1002/ptr.6800
10.1002/ptr.6800 · External reference
Obesity, leptin and breast cancer: epidemiological evidence and proposed mechanisms
10.3390/cancers11010062 · 2019 · External reference
Celastrol reduces obesity in MC4R deficiency and stimulates sympathetic nerve activity affecting metabolic and cardiovascular functions
10.2337/db18-1167 · 2019 · External reference
10.1038/nrclinonc.2016.120
10.1038/nrclinonc.2016.120 · External reference
10.1016/j.ejca.2017.10.006
10.1016/j.ejca.2017.10.006 · External reference
10.1016/j.semcancer.2017.04.015
10.1016/j.semcancer.2017.04.015 · External reference
Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells
10.1002/ijc.25010 · 2010 · External reference
10.18632/oncotarget.22684
10.18632/oncotarget.22684 · External reference
